Turner syndrome

Turner syndrome
Name	Turner syndrome
Diseasesdb	12938
Icd10	Q96
Icd9	758.6

Turner syndrome is a genetic disorder that affects approximately 1 in every 2,500 American females, with notable cases including Linda Hunt, Andrea Jaeger, and Kimberly Zieselman. This condition is characterized by the partial or complete absence of one X chromosome, which is a crucial component of the Human Genome Project. Individuals with Turner syndrome often experience a range of physical and developmental challenges, including short stature, heart defects, and learning disabilities, which can be addressed through treatment at institutions like the National Institutes of Health and the Children's Hospital of Philadelphia. Researchers, such as Dr. Henry Turner, have made significant contributions to the understanding of this condition, which is also supported by organizations like the Turner Syndrome Society of the United States and the European Society of Human Genetics.

Introduction

Turner syndrome is a complex condition that affects females, with a range of symptoms and characteristics that can vary in severity. The condition was first described by Dr. Henry Turner in 1938, and since then, significant advances have been made in the understanding and management of the condition, thanks to the work of researchers like Dr. Albert de la Chapelle and Dr. Park Gerald. Individuals with Turner syndrome often experience short stature, which can be treated with growth hormone therapy, as recommended by the American Academy of Pediatrics and the Endocrine Society. They may also have heart defects, such as bicuspid aortic valve, which can be diagnosed and treated at institutions like the Cleveland Clinic and the Mayo Clinic. Additionally, individuals with Turner syndrome may experience learning disabilities, such as difficulties with math and spatial reasoning, which can be addressed through educational programs at institutions like the University of California, Los Angeles and the University of Oxford.

Causes

The causes of Turner syndrome are complex and multifactorial, involving the loss or alteration of genetic material on the X chromosome, which is a critical component of the Human Genome Project. This can occur due to a range of factors, including meiosis, mitosis, and genetic mutation, which can be studied using techniques like karyotyping and fluorescence in situ hybridization at institutions like the National Center for Biotechnology Information and the European Bioinformatics Institute. The condition can also be caused by mosaicism, where a mixture of normal and abnormal cells is present, which can be diagnosed using techniques like microarray analysis and next-generation sequencing at institutions like the Broad Institute and the Wellcome Sanger Institute. Researchers, such as Dr. David Page and Dr. Mary Lyon, have made significant contributions to the understanding of the genetic basis of Turner syndrome, which is also supported by organizations like the National Institute of Child Health and Human Development and the European Society of Human Genetics.

Symptoms

The symptoms of Turner syndrome can vary in severity and range, but often include short stature, heart defects, and learning disabilities. Individuals with the condition may also experience a range of other symptoms, including hearing loss, vision problems, and thyroid disorders, which can be diagnosed and treated at institutions like the Johns Hopkins University and the University of California, San Francisco. They may also have difficulties with social and emotional development, which can be addressed through programs at institutions like the Yale University and the University of Cambridge. In some cases, individuals with Turner syndrome may experience infertility, which can be addressed through fertility treatments at institutions like the Boston IVF and the New York Fertility Institute. Researchers, such as Dr. Judith Hall and Dr. Michael Silberbach, have made significant contributions to the understanding of the symptoms and characteristics of Turner syndrome, which is also supported by organizations like the Turner Syndrome Society of the United States and the European Society of Human Genetics.

Diagnosis

The diagnosis of Turner syndrome typically involves a range of tests and evaluations, including karyotyping, fluorescence in situ hybridization, and physical examination, which can be performed at institutions like the Columbia University Medical Center and the University of Pennsylvania Health System. A diagnosis of Turner syndrome can be made prenatally, using techniques like amniocentesis and chorionic villus sampling, which can be performed at institutions like the New York-Presbyterian Hospital and the University of California, Los Angeles. In some cases, a diagnosis may not be made until later in life, when symptoms become more apparent, which can be addressed through treatment at institutions like the National Institutes of Health and the Children's Hospital of Philadelphia. Researchers, such as Dr. Joe Leigh Simpson and Dr. Laird Jackson, have made significant contributions to the development of diagnostic techniques for Turner syndrome, which is also supported by organizations like the American College of Medical Genetics and the European Society of Human Genetics.

Management

The management of Turner syndrome typically involves a range of treatments and interventions, including growth hormone therapy, heart surgery, and educational programs. Individuals with the condition may also require ongoing medical care and monitoring, including regular check-ups with a pediatrician or endocrinologist, which can be provided at institutions like the Children's Hospital of Philadelphia and the Boston Children's Hospital. In some cases, individuals with Turner syndrome may require fertility treatments, such as in vitro fertilization or egg donation, which can be provided at institutions like the New York Fertility Institute and the Boston IVF. Researchers, such as Dr. John Carey and Dr. Michael Belfort, have made significant contributions to the development of management strategies for Turner syndrome, which is also supported by organizations like the Turner Syndrome Society of the United States and the European Society of Human Genetics.

Epidemiology

The epidemiology of Turner syndrome is complex and multifactorial, involving a range of genetic and environmental factors. The condition affects approximately 1 in every 2,500 American females, with a higher incidence in certain populations, such as Hispanic and African American females, which can be studied using data from institutions like the Centers for Disease Control and Prevention and the National Center for Health Statistics. Researchers, such as Dr. Cynthia Morton and Dr. Stuart Schwartz, have made significant contributions to the understanding of the epidemiology of Turner syndrome, which is also supported by organizations like the National Institute of Child Health and Human Development and the European Society of Human Genetics. The condition is often diagnosed in childhood, but in some cases, it may not be diagnosed until later in life, which can be addressed through treatment at institutions like the National Institutes of Health and the Children's Hospital of Philadelphia. Overall, Turner syndrome is a significant public health concern, with important implications for the health and well-being of affected individuals, which can be addressed through programs at institutions like the World Health Organization and the European Centre for Disease Prevention and Control.

Category:Genetic disorders